 |
Breast cancer researchers at the University of Michigan recently garnered a $3.5 million grant from Susan G. Komen for the Cure® to study cancer stem cells in an aggressive subtype of breast cancer that disproportionately affects African-American women, called triple-negative breast cancer. more
|
|
More than a thousand U-M cancer patients each year rely on the Comprehensive Cancer Center's innovative music therapy program to reduce anxiety, ease pain and nausea, and improve their quality of life during cancer treatments. Now, thanks to the vision and generosity of Bill and Dee Brehm, this program will continue to lift the spirits and wellbeing of cancer patients, in perpetuity. more
|
 |
|
A new urine test can help aid early detection of, and treatment decisions about, prostate cancer, according to a new study conducted by U-M prostate cancer researchers. more
|
U-M pancreatic cancer researchers have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases, and normal blood serum. more
|
|
Researchers at the U-M's Comprehensive Cancer Center have developed a new drug called AT-406, which has the potential to treat multiple types of cancer. more
|
It's not how old but how frail patients are that can predict how well they will fare after a melanoma diagnosis. In fact, young patients in poor health may have worse outcomes than older patients in good shape. more
|
|
|
Director's Letter |
|
Welcome to the first issue of the new U-M cancer e-newsletter. We are excited to share with you some of the important work happening here at the Comprehensive Cancer Center to advance the treatment of cancer. more
|
 |
|
